โ
๐ ๐๐๐ฌ๐ฎ๐ฅ๐ญ๐ฌ
โข Revenue: $1.88B (+8.1% YoY; +7.3% core)
โข GAAP Operating Margin: 23.6% (+290 bps YoY)
โข Adj. Operating Margin: 28.3% (+320 bps YoY)
โข GAAP EPS: $1.28 (+8% YoY)
โข Adj. EPS: $1.62 (+18% YoY)
โข Adj. Net Income: $459M
โ
๐ฏ ๐๐ฎ๐ข๐๐๐ง๐๐
โข Q4 Revenue: $1.98Bโ$2.00B (+6.4% to +7.4%; +5.2% to +6.2% core)
โข Q4 Adj. EPS: $1.71โ$1.74
โข FY26 Revenue: $7.49Bโ$7.51B (+7.8% to +8.1%; +5.8% to +6.0% core)
โข FY26 Adj. Operating Margin Expansion: >130 bps
โข FY26 Adj. EPS: $6.18โ$6.21
โ
๐ ๐๐๐ฒ ๐๐๐ค๐๐๐ฐ๐๐ฒ๐ฌ
โข Agilent raised its FY26 revenue growth, operating margin expansion and Adj. EPS outlook, with the EPS midpoint increasing by $0.15 versus prior guidance
โข Growth was broad-based across all three segments: Life Sciences & Diagnostics +11%, CrossLab +6%, and Applied Markets +7% YoY
โข Q3 Adj. EPS included a $0.06 benefit from tariff refunds, while Q4 guidance assumes no additional tariff-refund benefit
โ
๐ฌ ๐๐๐ง๐๐ ๐๐ฆ๐๐ง๐ญ ๐๐จ๐ฆ๐ฆ๐๐ง๐ญ๐๐ซ๐ฒ
โWe are seeing improving end markets, stronger demand in key regions, and excellent customer response to our innovative product launches.โ